DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients - PubMed (original) (raw)
. 2008 Dec;45(12):808-12.
doi: 10.1136/jmg.2008.058594. Epub 2008 Aug 12.
Affiliations
- PMID: 18697824
- DOI: 10.1136/jmg.2008.058594
DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients
I Castaldo et al. J Med Genet. 2008 Dec.
Abstract
Background: The most frequent mutation of Friedreich ataxia (FRDA) is the abnormal expansion of a GAA repeat located within the first intron of FXN gene. It is known that the length of GAA is directly correlated with disease severity. The effect of mutation is a severe reduction of mRNA. Recently, a link among aberrant CpG methylation, chromatin organisation and GAA repeat was proposed.
Methods: In this study, using pyrosequencing technology, we have performed a quantitative analysis of the methylation status of five CpG sites located within the region upstream of GAA repeat, in 67 FRDA patients.
Results: We confirm previous observation about differences in the methylation degree between FRDA individuals and controls. We showed a direct correlation between CpG methylation and triplet expansion size. Significant differences were found for each CpG tested (ANOVA p<0.001). These differences were largest for CpG1 and CpG2: 84.45% and 76.80%, respectively, in FRDA patients compared to 19.65% and 23.34% in the controls. Most importantly, we found a strong inverse correlation between CpG2 methylation degree and age of onset (Spearman's rho = -0.550, p<0.001).
Conclusion: Because epigenetic changes may cause or contribute to gene silencing, our data may have relevance for the therapeutic approach to FRDA. Since the analysis can be performed in peripheral blood leucocytes (PBL), evaluation of the methylation status of specific CpG sites in FRDA patients could be a convenient biomarker.
Similar articles
- The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, Sandi C, Trabzuni D, Pook M. Al-Mahdawi S, et al. Hum Mol Genet. 2008 Mar 1;17(5):735-46. doi: 10.1093/hmg/ddm346. Epub 2007 Nov 27. Hum Mol Genet. 2008. PMID: 18045775 - FXN methylation predicts expression and clinical outcome in Friedreich ataxia.
Evans-Galea MV, Carrodus N, Rowley SM, Corben LA, Tai G, Saffery R, Galati JC, Wong NC, Craig JM, Lynch DR, Regner SR, Brocht AF, Perlman SL, Bushara KO, Gomez CM, Wilmot GR, Li L, Varley E, Delatycki MB, Sarsero JP. Evans-Galea MV, et al. Ann Neurol. 2012 Apr;71(4):487-97. doi: 10.1002/ana.22671. Ann Neurol. 2012. PMID: 22522441 - Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.
Pandolfo M. Pandolfo M. Methods Mol Med. 2006;126:197-216. doi: 10.1385/1-59745-088-X:197. Methods Mol Med. 2006. PMID: 16930014 - [Friedreich ataxia with GAA repeat expansion: molecular mechanism and clinical feature].
Tanaka H. Tanaka H. Nihon Rinsho. 1999 Apr;57(4):960-6. Nihon Rinsho. 1999. PMID: 10222797 Review. Japanese. - Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
Evans-Galea MV, Lockhart PJ, Galea CA, Hannan AJ, Delatycki MB. Evans-Galea MV, et al. Discov Med. 2014 Jan;17(91):25-35. Discov Med. 2014. PMID: 24411698 Review.
Cited by
- Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
Polak U, Li Y, Butler JS, Napierala M. Polak U, et al. Stem Cells Dev. 2016 Dec 1;25(23):1788-1800. doi: 10.1089/scd.2016.0147. Epub 2016 Oct 17. Stem Cells Dev. 2016. PMID: 27615158 Free PMC article. - FAST-1 antisense RNA epigenetically alters FXN expression.
Mikaeili H, Sandi M, Bayot A, Al-Mahdawi S, Pook MA. Mikaeili H, et al. Sci Rep. 2018 Nov 21;8(1):17217. doi: 10.1038/s41598-018-35639-2. Sci Rep. 2018. PMID: 30464193 Free PMC article. - Friedreich ataxia: clinical features and new developments.
Keita M, McIntyre K, Rodden LN, Schadt K, Lynch DR. Keita M, et al. Neurodegener Dis Manag. 2022 Oct;12(5):267-283. doi: 10.2217/nmt-2022-0011. Epub 2022 Jun 29. Neurodegener Dis Manag. 2022. PMID: 35766110 Free PMC article. Review. - Hereditary Ataxia: A Focus on Heme Metabolism and Fe-S Cluster Biogenesis.
Chiabrando D, Bertino F, Tolosano E. Chiabrando D, et al. Int J Mol Sci. 2020 May 26;21(11):3760. doi: 10.3390/ijms21113760. Int J Mol Sci. 2020. PMID: 32466579 Free PMC article. Review. - Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease.
Clark E, Johnson J, Dong YN, Mercado-Ayon E, Warren N, Zhai M, McMillan E, Salovin A, Lin H, Lynch DR. Clark E, et al. Neuronal Signal. 2018 Nov 2;2(4):NS20180060. doi: 10.1042/NS20180060. eCollection 2018 Dec. Neuronal Signal. 2018. PMID: 32714592 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous